Colgate-Palmolive Company (NYSE:CL) Shares Sold by Blair William & Co. IL

Key Points

• Blair William & Co. IL has reduced its stake in Colgate-Palmolive by 5.9%, owning 253,569 shares worth approximately $23.76 million after selling 16,038 shares in Q1.
• Colgate-Palmolive announced a quarterly dividend of $0.52, with an ex-dividend date set for July 18, resulting in an annualized dividend of $2.08 and a yield of 2.5%.
• Institutional investors own 80.41% of Colgate-Palmolive's stock, and recent analyst price targets reflect a consensus expectation of $100.58 for the company's shares.

Blair William & Co. IL lessened its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 5.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 253,569 shares of the company's stock after selling 16,038 shares during the quarter. Blair William & Co. IL's holdings in Colgate-Palmolive were worth $23,759,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Deutsche Bank AG lifted its stake in Colgate-Palmolive by 35.6% during the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock valued at $629,369,000 after purchasing an additional 1,816,865 shares during the last quarter. Diamond Hill Capital Management Inc. increased its stake in shares of Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company's stock worth $521,250,000 after purchasing an additional 1,727,105 shares during the last quarter. Castlekeep Investment Advisors LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $111,738,000. Renaissance Technologies LLC boosted its holdings in Colgate-Palmolive by 70.2% in the 4th quarter. Renaissance Technologies LLC now owns 2,808,110 shares of the company's stock valued at $255,285,000 after purchasing an additional 1,158,060 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Colgate-Palmolive by 10,601.7% in the 1st quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company's stock valued at $103,574,000 after purchasing an additional 1,095,050 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.4%

NYSE CL opened at $83.51 on Monday. The company has a current ratio of 0.43, a quick ratio of 0.28 and a debt-to-equity ratio of 8.96. The company has a market capitalization of $67.68 billion, a PE ratio of 23.46, a price-to-earnings-growth ratio of 4.31 and a beta of 0.35. Colgate-Palmolive Company has a 1-year low of $82.70 and a 1-year high of $109.30. The firm's fifty day simple moving average is $89.59 and its 200-day simple moving average is $90.31.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.91 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is 58.76%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CL. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating for the company in a report on Friday, July 25th. Barclays raised their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. UBS Group lowered their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Citigroup lifted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $100.58.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.